Search details
1.
Barriers and facilitators for adopting healthy lifestyles in breast cancer survivors: a scoping review protocol.
JBI Evid Synth
; 21(11): 2218-2226, 2023 Nov 01.
Article
in English
| MEDLINE | ID: mdl-37395535
2.
New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review.
Cancers (Basel)
; 15(13)2023 Jun 22.
Article
in English
| MEDLINE | ID: mdl-37444400
3.
Management Strategies for Hyperglycemia Associated with the α-Selective PI3K Inhibitor Alpelisib for the Treatment of Breast Cancer.
Cancers (Basel)
; 14(7)2022 Mar 22.
Article
in English
| MEDLINE | ID: mdl-35406370
4.
Clinical Validation of EndoPredict in Pre-Menopausal Women with ER-Positive, HER2-Negative Primary Breast Cancer.
Clin Cancer Res
; 28(20): 4435-4443, 2022 10 14.
Article
in English
| MEDLINE | ID: mdl-36043530
5.
Combination therapy of lapatinib and Capecitabine for ErbB2-positive metastatic or locally advanced breast cancer: results from the Lapatinib Expanded Access Program (LEAP) in Central and Eastern Europe.
Onkologie
; 34(5): 233-8, 2011.
Article
in English
| MEDLINE | ID: mdl-21577028
6.
Combination of a 15-SNP Polygenic Risk Score and Classical Risk Factors for the Prediction of Breast Cancer Risk in Cypriot Women.
Cancers (Basel)
; 13(18)2021 Sep 11.
Article
in English
| MEDLINE | ID: mdl-34572793
7.
Genetic variation in genes interacting with BRCA1/2 and risk of breast cancer in the Cypriot population.
Breast Cancer Res Treat
; 121(1): 147-56, 2010 May.
Article
in English
| MEDLINE | ID: mdl-19714462
8.
An investigation of breast cancer risk factors in Cyprus: a case control study.
BMC Cancer
; 10: 447, 2010 Aug 23.
Article
in English
| MEDLINE | ID: mdl-20727220
9.
Real-World Setting Cost-Effectiveness Analysis Comparing Three Therapeutic Schemes of One-Year Adjuvant Trastuzumab in HER2-Positive Early Breast Cancer from the Cyprus NHS Payer Perspective.
Int J Environ Res Public Health
; 17(12)2020 06 17.
Article
in English
| MEDLINE | ID: mdl-32560485
10.
NGS Panel Testing of Triple-Negative Breast Cancer Patients in Cyprus: A Study of BRCA-Negative Cases.
Cancers (Basel)
; 12(11)2020 Oct 27.
Article
in English
| MEDLINE | ID: mdl-33120919
11.
DNA-repair genetic polymorphisms and risk of breast cancer in Cyprus.
Breast Cancer Res Treat
; 115(3): 623-7, 2009 Jun.
Article
in English
| MEDLINE | ID: mdl-18553220
12.
Radiotherapy capacity in Europe.
Lancet Oncol
; 14(6): e196, 2013 May.
Article
in English
| MEDLINE | ID: mdl-23639316
13.
Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus.
Breast Cancer Res Treat
; 112(3): 575-9, 2008 Dec.
Article
in English
| MEDLINE | ID: mdl-18188695
14.
Epidemiology of breast cancer in Cyprus: Data on newly diagnosed cases and survival rates.
Data Brief
; 19: 353-369, 2018 Aug.
Article
in English
| MEDLINE | ID: mdl-29892657
15.
Guided Imagery And Progressive Muscle Relaxation as a Cluster of Symptoms Management Intervention in Patients Receiving Chemotherapy: A Randomized Control Trial.
PLoS One
; 11(6): e0156911, 2016.
Article
in English
| MEDLINE | ID: mdl-27341675
16.
Single-nucleotide polymorphisms in one-carbon metabolism genes, Mediterranean diet and breast cancer risk: a case-control study in the Greek-Cypriot female population.
Genes Nutr
; 10(2): 453, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-25604861
17.
The mutational spectrum of Lynch syndrome in cyprus.
PLoS One
; 9(8): e105501, 2014.
Article
in English
| MEDLINE | ID: mdl-25133505
Results
1 -
17
de 17
1
Next >
>>